Advertisement

Topics

Obesity may promote resistance to antiangiogenic therapy for breast cancer

20:00 EDT 13 Mar 2018 | AAAS

(Massachusetts General Hospital) A research team led by Massachusetts General Hospital investigators has found, for the first time, that obesity and obesity-related molecular factors appear to induce resistance to antiangiogenic therapy in breast cancer patients and in mouse models of the disease.

Original Article: Obesity may promote resistance to antiangiogenic therapy for breast cancer

NEXT ARTICLE

More From BioPortfolio on "Obesity may promote resistance to antiangiogenic therapy for breast cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...